| Dr Laura Owens Bakey, MD | |
|
500 N Bridge St, Bridgewater, NJ 08807-2135 | |
| (908) 725-2800 | |
| (908) 704-1790 |
| Full Name | Dr Laura Owens Bakey |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 500 N Bridge St, Bridgewater, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063599496 | NPI | - | NPPES |
| 527486 | Other | NJ | AGENCY MEDICARE # |
| 0023701 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 25MA05208200 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Laura Owens Bakey, MD 500 N Bridge St, Bridgewater, NJ 08807-2135 Ph: (908) 725-2800 | Dr Laura Owens Bakey, MD 500 N Bridge St, Bridgewater, NJ 08807-2135 Ph: (908) 725-2800 |
News Archive
Results from the largest study of artificial intelligence use in the English Diabetic Eye Screening Programme (DESP), have shown that the technology can accurately detect serious eye disease among those with diabetes (retinopathy) and could halve the human workload associated with screening for diabetic eye disease, saving millions of pounds annually.
Frequent spitting up, irritability, and unexplained crying in infants can be very distressing to parents. Pediatricians often prescribe acid-suppressing drugs for these symptoms in an effort to treat infants for gastroesophageal reflux disease (GERD); however, GERD is an uncommon cause of these symptoms in otherwise thriving infants.
The results of a double-blind, randomized, multisite placebo-controlled trial that was conducted in South Africa show that Oxford's ChAdOx1 nCoV-19 (AZD1222) vaccine has no efficacy against the B.1.351 variant in preventing mild-to-moderate coronavirus disease 2019 (COVID-19), and shows reduced neutralization properties of developed antibodies. The findings are published in the New England Journal of Medicine.
Takeda Pharmaceutical Company Limited today announced results from the phase 3 VISIBLE 1 clinical trial evaluating the efficacy and safety of an investigational subcutaneous formulation of the gut-selective biologic vedolizumab for maintenance therapy in adult patients with moderately to severely active ulcerative colitis who achieved clinical response* at week 6 following two doses of open-label vedolizumab intravenous induction therapy.
Weather forecasts could become barometers for predicting the potential threat of West Nile virus to humans and wildlife, according to scientists at two state agencies based at the University of Illinois at Urbana-Champaign.
› Verified 3 days ago
Dr. Justin Joseph Lo Re, D.O. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1125 Route 22 Ste 155, Bridgewater, NJ 08807 Phone: 732-667-1123 Fax: 732-560-3206 | |
Dr. Marcella S Bernson, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 500 N Bridge St, Bridgewater, NJ 08807 Phone: 908-725-2800 Fax: 908-704-1790 | |
Henry Odunlami, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 380 Foothill Rd Ste 1, Bridgewater, NJ 08807 Phone: 908-231-0511 Fax: 908-231-1115 | |
Dr. Tasneem Shaikh, M.D Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 500 N Bridge St, Bridgewater, NJ 08807 Phone: 908-725-2800 Fax: 908-704-1790 | |
Hailing Zhang, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 215 Union Ave, Suite E, Bridgewater, NJ 08807 Phone: 908-685-0556 Fax: 908-685-0480 | |
Vinay Arya, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 500 N Bridge St, Bridgewater, NJ 08807 Phone: 908-253-3163 Fax: 908-704-1790 |